Cytomel and Cellulitis aggravated - a phase IV clinical study of FDA data

Summary:

Cellulitis aggravated is reported as a side effect among people who take Cytomel (liothyronine sodium), especially for people who are female, 60+ old, also take Synthroid, and have Hypopituitarism.

The phase IV clinical study analyzes which people have Cellulitis aggravated when taking Cytomel. It is created by eHealthMe based on reports of 6,807 people who have side effects when taking Cytomel from the FDA, and is updated regularly.

What is Cytomel?

Cytomel has active ingredients of liothyronine sodium. It is often used in hypothyroidism. eHealthMe is studying from 7,595 Cytomel users. Check the latest studies of Cytomel.

What is Cellulitis aggravated?

Cellulitis aggravated (worst condition of inaction under skin) is found to be associated with 1,536 drugs and 617 conditions by eHealthMe. Check the latest studies of Cellulitis aggravated.

On Jul, 14, 2026

6,807 people reported to have side effects when taking Cytomel.
Among them, 27 people (0.4%) have Cellulitis aggravated.

Could Cytomel cause Cellulitis aggravated?

Among these 27 people:

What is the gender of people who have Cellulitis aggravated when taking Cytomel? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Cellulitis aggravated when taking Cytomel? *

What are other drugs people take besides Cytomel? *

What are other side effects people have besides Cellulitis aggravated? *

Infection: 11 people, 40.74%
Sinusitis (inflammation of sinus): 10 people, 37.04%
Headache (pain in head): 7 people, 25.93%
Nausea (feeling of having an urge to vomit): 7 people, 25.93%
Pain: 6 people, 22.22%
Fatigue (feeling of tiredness): 6 people, 22.22%
Fever: 5 people, 18.52%
Paraesthesia Oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect): 5 people, 18.52%
Weakness: 5 people, 18.52%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 4 people, 14.81%

What are the existing conditions these people have? *

Growth Hormone Deficiency: 5 people, 18.52%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 5 people, 18.52%
Primary Immunodeficiency Syndrome: 4 people, 14.81%
Immune System Disorder: 2 people, 7.41%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 2 people, 7.41%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 7.41%
Hypergammaglobulinaemia (elevated levels of gamma globulin): 2 people, 7.41%
Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 7.41%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 3.70%
Addison's Disease (addison's disease, a hormonal disorder disease): 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Cytomel and have Cellulitis aggravated?

- Check whether Cellulitis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cytomel:

Cytomel (7,595 reports)

Browse all side effects of Cytomel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cellulitis aggravated:

Cellulitis aggravated (1,536 drugs)

Browse all the conditions that are associated with Cellulitis aggravated:

Cellulitis aggravated (617 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on liothyronine sodium (the active ingredients of Cytomel) and Cytomel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.